Middle East Pharmaceutical Company Ltd.
4016XSAUSaudi Exchange·Healthcare
SAR 61.60
▲︎ 0.98%(+0.60)
Live
Data as of 11 Jun 2026
Open
SAR 61.00
High
SAR 62.05
Low
SAR 60.70
Volume
193.2K
52W High
SAR 138.40
52W Low
SAR 56.60
1W
+4.58%
1M
+6.48%
3M
-37.87%
6M
-44.85%
YTD
-45.49%
1Y
-52.02%
Mīzān Analysis
38/60
High income with solid fundamentals
High VolatilityData as of 14 Jun 2026 — may be outdated
4016Sector
Market Cap
2.1B SAR
P/E
19.4
Revenue Growth
16.9%
Div Yield
4.10%
Rewards
No standout positive signals at current scores.
Risk Analysis
No significant risk flags at current scores.
Scores computed 14 Jun 2026
Fundamentals
Market Cap
P/E Ratio
P/B Ratio
EPS
EPS Growth
Revenue
Revenue Growth
Net Income
Profit Margin
Debt / Assets
Dividend Yield
Dividend Per Share
Shares Outstanding
Reporting Period: 2025-12-31Data as of May 22, 2026
Mizān Summary
News
Sector News10Industry & macro context
Abu Dhabi launches automated medical insurance scheme for all arriving Etihad Airways travelers
Economy Middle East· 3 days agoNeutral
Sheikh Mohammed launches Dubai Longevity Authority to drive healthcare innovation, investment
Economy Middle East· 5 days agoNeutral
Industry Minister Opens Bahrain–Hungary Industrial Partnership Forum
News of Bahrain· 5 days agoNeutralEconomy
Dubai-France non-oil trade surges 120 percent in five years to $10.97 billion
Economy Middle East· 6 days agoNeutral
Sheikh Mohammed approves reconstitution of Emirates Health Services board of directors
Economy Middle East· 6 days agoNeutral
UAE Ministry of Health confirms no Ebola cases detected in the country
Economy Middle East· 11 days ago
Dubai plans new visa to aid medical tourism
AGBI· 12 days agoNeutral
Dubai planning new visa to aid medical tourism
AGBI· 12 days ago
Estithmar enlists Rothschild for healthcare IPO in Qatar
AGBI· 25 days agoNeutral
UK-Gulf trade deal a 'monumental achievement,' Bahrain trade minister tells CNBC
CNBC· 25 days agoPositiveEconomy
